AF
CINC

Amalgamated Financial’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Amalgamated Financial’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$40K Buy
+2,271
New +$46.6K ﹤0.01% 2528

Other funds holding CINC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Amalgamated Financial's CINC Position: Q1 2022 in Review

Amalgamated Financial opened a new position in CinCor Pharma, Inc. Common Stock (CINC) in Q1 2022: 2,271 shares worth $40K. The stake represents ﹤0.01% of the portfolio and ranks #2528 among its holdings.

53 funds tracked by Wall St. Rank hold CINC as of Q1 2022.

  • Amalgamated Financial held 2,271 shares of CinCor Pharma, Inc. Common Stock worth $40K as of Q1 2022.
  • CinCor Pharma, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
  • CinCor Pharma, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2528 holding.
  • 53 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.